230 related articles for article (PubMed ID: 9399495)
1. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
[TBL] [Abstract][Full Text] [Related]
2. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
4. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
[TBL] [Abstract][Full Text] [Related]
5. Mapping of serotype-specific, immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2, and 3.
Simmonds P; Rose KA; Graham S; Chan SW; McOmish F; Dow BC; Follett EA; Yap PL; Marsden H
J Clin Microbiol; 1993 Jun; 31(6):1493-503. PubMed ID: 7686182
[TBL] [Abstract][Full Text] [Related]
6. Localization and reactivity of an immunodominant domain in the NS3 region of hepatitis C virus.
Claeys H; Volckaerts A; Mertens W; Liang Z; Fiten P; Opdenakker G
J Med Virol; 1995 Mar; 45(3):273-81. PubMed ID: 7539833
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection in children with hemophilia: characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction.
Kanesaki T; Kinoshita S; Tsujino G; Yoshioka K; Ikegami N
J Pediatr; 1993 Sep; 123(3):381-7. PubMed ID: 7689096
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
[TBL] [Abstract][Full Text] [Related]
9. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
[TBL] [Abstract][Full Text] [Related]
10. Genotypes of hepatitis C virus in Nigeria.
Oni AO; Harrison TJ
J Med Virol; 1996 Jul; 49(3):178-86. PubMed ID: 8818962
[TBL] [Abstract][Full Text] [Related]
11. The immunoreactivity profile of different HCV genotypes on immunoblot assay and its implications in the development of diagnostic assays.
Kanistanon D; Neelamek M; Dharakul T; Songsivilai S
Asian Pac J Allergy Immunol; 1997 Sep; 15(3):133-40. PubMed ID: 9438545
[TBL] [Abstract][Full Text] [Related]
12. Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong.
Prescott LE; Simmonds P; Lai CL; Chan NK; Pike I; Yap PL; Lin CK
J Med Virol; 1996 Oct; 50(2):168-75. PubMed ID: 8915883
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences.
Yun Z; Lara C; Johansson B; Lorenzana de Rivera I; Sönnerborg A
J Med Virol; 1996 Jul; 49(3):155-60. PubMed ID: 8818959
[TBL] [Abstract][Full Text] [Related]
14. Antigenic heterogeneity of the NS3 proteins in hepatitis C virus genotypes 1 and 6.
Qiao W; Xie P; Cai B; Li L
Intervirology; 2011 Feb; 54(2):53-60. PubMed ID: 20829600
[TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.
Kelly C; Swadling L; Brown A; Capone S; Folgori A; Salio M; Klenerman P; Barnes E
Eur J Immunol; 2015 Jan; 45(1):309-16. PubMed ID: 25263407
[TBL] [Abstract][Full Text] [Related]
16. Antigenic heterogeneity of the hepatitis C virus NS5A protein.
Dou XG; Talekar G; Chang J; Dai X; Li L; Bonafonte MT; Holloway B; Fields HA; Khudyakov YE
J Clin Microbiol; 2002 Jan; 40(1):61-7. PubMed ID: 11773093
[TBL] [Abstract][Full Text] [Related]
17. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
[TBL] [Abstract][Full Text] [Related]
18. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
Zhang ZX; Chen M; Sönnerborg A; Sällberg M
Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus nonstructural 3 protein: recombinant NS3 protein of the Thai isolates as an antigen in a diagnostic assay.
Kanistanon D; Wongprompitak P; Dharakul T; Songsivilai S
Asian Pac J Allergy Immunol; 2002 Sep; 20(3):161-6. PubMed ID: 12587839
[TBL] [Abstract][Full Text] [Related]
20. Significance of specific antibody assay for genotyping of hepatitis C virus.
Tanaka T; Tsukiyama-Kohara K; Yamaguchi K; Yagi S; Tanaka S; Hasegawa A; Ohta Y; Hattori N; Kohara M
Hepatology; 1994 Jun; 19(6):1347-53. PubMed ID: 7514558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]